Malignant mesothelioma is a rare form of cancer caused mainly by exposure to asbestos. Currently, only 0.3 of all cancer patients are diagnosed with mesothelioma each year. There are a few mesothelioma treatments, but presently there is no cure. The best medical specialists who can treat this type of cancer are physicians who are trained to deal with asbestos-related diseases.
With more than $30 billion currently set aside in trust funds, you may qualify for substantial compensation if you’ve been diagnosed with mesothelioma, asbestosis, or asbestos-related lung cancer. Fill out our form to receive our free Financial Compensation Packet. Our packet is loaded with information on experienced mesothelioma attorneys in your area, how to file a claim for asbestos trust funds, how to get paid in 90 days, and more.
Since mesothelioma is so rare, patients who are diagnosed require the best oncologists and surgeons to provide the proper treatment. A handful of specialists located in hospitals and medical schools across the U.S. provides this specialized care and helps improve the quality of life for mesothelioma cancer patients.
Dr. Robert Cameron, MD, UCLA Health System, Los Angeles, CA
A 1984 graduate of the UCLA School of Medicine, specializes in surgical oncology and thoracic surgery.
Currently affiliated with the Ronald Reagan UCLA Medical Center, Dr. Cameron is certified in thoracic surgery by the American Board of Thoracic Surgery and surgery by the American Board of Surgery.
Dr. Hedy Lee Kindler, MD, University of Chicago, Chicago, IL
Dr. Kindler is presently the director of the University of Chicago’s Mesothelioma Program; she’s also an associate professor of medicine and the medical director of UC’s department of gastrointestinal oncology.
Dr. Kindler started her practice in 1995 and is an internationally recognized expert on various types of cancer, including malignant mesothelioma.
Listed several times over the past few years in Best Doctors in America and America’s Top Doctors for Cancer, Dr. Kindler is a recipient of the Asbestos Disease Awareness Organization’s Selikoff Lifetime Achievement Award.
David C. Rice, M.B., B.Ch., B.A.O.; F.R.C.S.I., The University of Texas M.D. Anderson Cancer Center, Houston, TX
Dr. Rice is presently an associate professor at the University of Texas’ Department of Thoracic and Cardiovascular Surgery, Division of Surgery. A 1991 graduate of the School of Medicine, Trinity College, Dublin (Ireland), Dr. Rice continued his medical training in Minnesota’s Mayo Clinic and Houston’s Baylor College of Medicine.
He is a Fellow of the Royal College of Surgeons of Ireland and has been on the faculty of the M.D. Anderson Cancer Center at UT Houston since 2001.
Although his other area of clinical interest is in minimally invasive surgery for thoracic malignancies, Dr. Rice is internationally renowned for his work on mesothelioma.
Lary Robinson, M.D., H.Lee Moffitt Cancer Center and Research Institute, Tampa, FL
Dr. Robinson is the director of the HLMCC’s Division of Cardiovascular and Thoracic Surgery. He is a 1972 graduate of the Washington University School of Medicine in St. Louis, MO.
He has over 40 years of experience in the medical profession, including his residency at Duke University Medical Center and a tour of duty as a flight surgeon in the Air Force. He has fellowships from London’s St. Thomas Hospital and Duke University Medical Center.
A member of the Science Advisory Board of the Mesothelioma Applied Research Foundation, Dr. Robinson’s principal research focuses on aggressive treatment of mesothelioma using surgical procedures.
Dr. Robinson is also a member of the American College of Surgeons and the American Association for Thoracic Surgery.
Stephen C. Yang, M.D., B.Ch., F.A.C.S., F.A.C.C, Johns Hopkins University School of Medicine, Baltimore, MD
Dr. Yang is a faculty member of the School of Medicine at Johns Hopkins’ Sidney Kimmel Comprehensive Cancer Center, where he teaches in the Surgery and Oncology Department.
He earned his medical degree from Virginia Commonwealth University in 1984. He also has a bachelor’s degree in chemistry from Duke University, and has a strong background in thoracic oncology.
In addition to his teaching post at Johns Hopkins, Dr. Yang is an attending surgeon at The Johns Hopkins Hospital and The Johns Hopkins Bayview Medical Center. His research interests include the development of markers for the early diagnosis of lung cancer and the molecular biology of mesothelioma.
Michael Slaughter, M.D., St. Francis Cancer Center, Indianapolis, IN:
A 1991 graduate of Meharry Medical College in Nashville, TN, Dr. Slaughter is a specialist in hematology and oncology at the St. Francis Cancer Center. An Internal Medicine Hospitalist, he is particularly focused on lung cancer, breast cancer, solid tumors, and colon cancer. He has medical licenses in Georgia, Indiana, and Texas.
Dr. Slaughter did his residency at the Jewish Hospital in Cincinnati, where he specialized in internal medicine. He also completed a fellowship at the University of Texas M.D. Anderson Cancer Center.
Michael J. Liptay, M.D., Rush University Medical Center, Chicago, IL:
Dr. Liptay earned his undergraduate and medical degrees from Northwestern University. He has been practicing medicine since 1991 and specializes in thoracic oncology. He is the chief of the Division of Thoracic Surgery and an associate professor in the Department of Cardiovascular-Thoracic Surgery at Rush University Medical Center.
Dr. Liptay is also researching techniques to detect, stage, and carry out the prognosis of lung cancer as early as possible.
He has worked with some of the top oncologists and mesothelioma experts in the U.S., including Dr. David Sugarbaker of Boston’s Bingham and Women’s Hospital. He has various leadership positions in many scientific and professional organizations, including the Illinois division of the American Cancer Society and the American College of Surgeons Oncology Group.
In Memory of Dr. David J. Sugarbaker, MD, Brigham and Women’s Hospital, Boston, MA
Along with being the Chief of the Division of Thoracic Surgery at Boston’s Brigham and Women’s Hospital, Dr. Sugarbaker was the Richard E. Wilson Professor of surgical oncology.
Graduating from Weill Medical College of Cornell University in 1979, he specialized in thoracic surgery, specifically focusing on lung and thoracic cancer. Dr. Sugarbaker’s clinical interests included general thoracic surgery, lung and pleural cancer, and mesothelioma.
In 2018, Dr. Sugarbaker passed away at the age of 65. He’s remembered as a “pioneer in the treatment of malignant pleural mesothelioma (MPM) for nearly 30 years,” according to NIH.
Getting Legal Help
Remember, if you’ve been diagnosed with mesothelioma or asbestos-related cancer, there is a good chance you’ll qualify for considerable compensation. Remember to fill out our from to get your free Financial Compensation Packet, with information on experienced asbestos and mesothelioma lawyers in your area.
Page Reviewed and Edited by Mesothelioma Attorney Paul Danziger
Paul Danziger grew up in Houston, Texas and earned a law degree from Northwestern University School of Law in Chicago. For over 25 years years he has focused on representing mesothelioma cancer victims and others hurt by asbestos exposure. Paul and his law firm have represented thousands of people diagnosed with mesothelioma, asbestosis, and lung cancer, recovering significant compensation for injured clients. Every client is extremely important to Paul and he will take every call from clients who want to speak with him. Paul and his law firm handle mesothelioma cases throughout the United States.